Scarica l'app Stockscreener
7.95
8.32%
0.62
Zevra Therapeutics Inc Borsa (ZVRA) Ultime notizie
First Drug to Stop NPC Disease Progression: Zevra's MIPLYFFA Shows Breakthrough Results in 270 Patients - Stock Titan
Zevra Therapeutics (NASDAQ:ZVRA) Director Purchases $24,733.25 in Stock - MarketBeat
Zevra Therapeutics (ZVRA) Announces Positive New Data Supporting Foundational Role of MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C - Yahoo Finance
RSI Check: Is Zevra Therapeutics Inc. in a long term uptrendQuarterly Earnings Summary & AI Driven Price Predictions - خودرو بانک
Zevra Therapeutics (NASDAQ:ZVRA) Downgraded by Wall Street Zen to Hold - MarketBeat
Insider Buying: Tamara Favorito Acquires Shares of Zevra Therapeutics Inc (ZVRA) - GuruFocus
A Fresh Look at Zevra Therapeutics (ZVRA) Valuation Following New MIPLYFFA Data Release - Yahoo Finance
Alvin Shih At Zevra Therapeutics Tops Up Holding By US$158k - simplywall.st
Alvin Shih Adds To Zevra Therapeutics Holding - uk.finance.yahoo.com
Published on: 2025-09-16 13:04:37 - خودرو بانک
Woodline Partners LP Raises Holdings in Zevra Therapeutics, Inc. $ZVRA - MarketBeat
Zevra Therapeutics gains amid takeover speculation - MSN
Insider Buying: Alvin Shih Acquires 20,000 Shares of Zevra Therapeutics Inc (ZVRA) - GuruFocus
Insider Trends: Can Zevra Therapeutics Inc sustain earnings growth2025 Growth vs Value & Accurate Intraday Trade Tips - خودرو بانک
Stock Report: What is the next catalyst for Zevra Therapeutics IncWeekly Profit Recap & Proven Capital Preservation Methods - خودرو بانک
Insider Trends: What is the next catalyst for Zevra Therapeutics IncSwing Trade & Fast Gaining Stock Strategy Reports - خودرو بانک
Aug Mood: Is Zevra Therapeutics Inc backed by strong institutional buyingJuly 2025 Price Swings & AI Powered Market Entry Strategies - خودرو بانک
Will Zevra Therapeutics Inc. rebound enough to break evenWeekly Trade Report & Low Risk Entry Point Guides - newser.com
What technical models suggest about Zevra Therapeutics Inc.’s comeback2025 Market WrapUp & Safe Capital Preservation Plans - newser.com
Visual trend scoring systems applied to Zevra Therapeutics Inc.2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com
Zevra Therapeutics (ZVRA): Evaluating Valuation After Positive MIPLYFFA Clinical Data Spurs Investor Interest - Sahm
Is Zevra Therapeutics Inc. forming a bottoming baseJuly 2025 Fed Impact & Weekly Setup with ROI Potential - newser.com
Is a relief rally coming for Zevra Therapeutics Inc. holdersBull Run & Free Safe Entry Trade Signal Reports - newser.com
Do Zevra Therapeutics' (ZVRA) New MIPLYFFA Data Reshape the Rare Disease Innovation Narrative? - Yahoo Finance
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Sees Large Growth in Short Interest - MarketBeat
Adage Capital Partners GP L.L.C. Reduces Stock Position in Zevra Therapeutics, Inc. $ZVRA - MarketBeat
Does Zevra Therapeutics Inc. have high return on assets2025 Market Overview & Growth Oriented Trading Recommendations - Lancaster City Council
Is Zevra Therapeutics Inc. stock a good dividend stockBuy Signal & Reliable Momentum Entry Alerts - Lancaster City Council
Moving Average Crossover Confirms Uptrend in Zevra Therapeutics Inc.July 2025 Intraday Action & Community Consensus Picks - beatles.ru
What You Can Learn From Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) P/S After Its 26% Share Price Crash - simplywall.st
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Shares Slammed 26% But Getting In Cheap Might Be Difficult Regardless - 富途牛牛
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives $23.71 Consensus PT from Analysts - MarketBeat
Is Zevra Therapeutics Inc. a strong growth stockWeekly Trade Report & Low Drawdown Momentum Trade Ideas - خودرو بانک
Retirement Planning Co of New England Inc. Purchases 35,348 Shares of Zevra Therapeutics, Inc. $ZVRA - MarketBeat
Zevra Therapeutics, Inc. $ZVRA Shares Sold by Nantahala Capital Management LLC - MarketBeat
What’s the recovery path for long term holders of Zevra Therapeutics Inc.Market Activity Recap & Free Community Consensus Stock Picks - Newser
Is Zevra Therapeutics Inc. a good ESG investmentGap Down & Free Verified High Yield Trade Plans - خودرو بانک
What analysts say about Zevra Therapeutics Inc. stockWeekly Profit Report & High Return Trade Opportunity Guides - خودرو بانک
Quantitative breakdown of Zevra Therapeutics Inc. recent moveQuarterly Investment Review & Long-Term Safe Return Strategies - Newser
Measuring Zevra Therapeutics Inc.’s beta against major indicesMarket Weekly Review & Precise Swing Trade Alerts - Newser
Using Python tools to backtest Zevra Therapeutics Inc. strategiesMarket Performance Summary & Advanced Technical Analysis Signals - Newser
Wellington Management Group LLP Makes New $1.05 Million Investment in Zevra Therapeutics, Inc. $ZVRA - MarketBeat
Zevra Therapeutics Inc. stock retracement – recovery analysisSell Signal & Safe Entry Momentum Tips - Newser
Using data models to predict Zevra Therapeutics Inc. stock movementStock Surge & Free Technical Confirmation Trade Alerts - Newser
Does Zevra Therapeutics Inc. qualify in momentum factor screeningWeekly Profit Report & Expert Curated Trade Setup Alerts - Newser
Volume spikes in Zevra Therapeutics Inc. stock – what they meanTrade Risk Report & Safe Entry Trade Signal Reports - Newser
What recovery options are there for Zevra Therapeutics Inc.July 2025 Market Mood & Reliable Entry Point Alerts - Newser
Zevra Therapeutics Presents Positive New Data Supporting - GlobeNewswire
Zevra Therapeutics Announces Positive Data for MIPLYFFA® in Niemann-Pick Disease Type C at ICIEM; Poster Nominated for Best Award - Quiver Quantitative
Zevra Therapeutics Presents Positive New Data Supporting Foundational Role of MIPLYFFA® (arimoclomol) for the Treatment of Niemann-Pick Disease Type C at the International Congress of Inborn Errors of Metabolism (ICIEM) - GlobeNewswire
Disease Progression Slowed: Zevra's MIPLYFFA Shows Breakthrough Results in Rare Niemann-Pick Disease Trial - Stock Titan
How does Zevra Therapeutics Inc. compare to its peersMarket Sentiment Review & AI Driven Stock Price Forecasts - خودرو بانک
What makes Zevra Therapeutics Inc. stock price move sharplyJuly 2025 Review & Expert Approved Momentum Ideas - Newser
Tools to monitor Zevra Therapeutics Inc. recovery probabilityEarnings Growth Report & High Return Stock Watch Alerts - Newser
0.07%
1.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):